OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms – ISS and Glass Lewis – Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE
Untitled
2022 Proxy Advisor Policies for Canada | Compensation
ISS and Glass Lewis Policy Updates for 2023 - Lexology
Glass Lewis Issues Updates to 2023 Policy Guidelines
Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend TA Shareholders Vote "FOR" Pending BP Transaction
Proxy firms ISS, Glass Lewis recommend Magellan Midsteam holders vote for Oneok deal | Seeking Alpha
Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend Vermilion Shareholders Vote FOR All Proposed Items at the Upcoming Annual General Meeting of Shareholders
The Powerful Private Regulator and the Effects of Conflicts of Interest - ProMarket
Are Top Investors Listening to Proxy Advisors on Pay?
ISS and Glass Lewis Policy Updates for 2023 - Lexology
Proxy advisers Glass Lewis, ISS disagree over Mediaset Dutch base move | Reuters
ISS vs. Glass Lewis: Understanding Both Points of View | Human Capital Solutions Insights
Heads Up for the 2019 Proxy Season: New and Revised ISS and Glass Lewis Policies May Impact Director Elections - Lexology
Updates to ISS & Glass Lewis Compensation & Related Policies - Meridian Compensation Partners
Proxy Advisors And Market Power: A Review of Institutional Investor Robovoting
Activists' Lack of Recent Success | FTI Consulting
Glass Lewis, ISS in Favor of Bayer Management Yet Against Pay - Bloomberg
Glass Lewis, ISS back McDonald's director nominees, not Icahn's
ISS and Glass Lewis Policy Updates for 2023 - Lexology
Glass Lewis and ISS Issue 2023 Updates | Wilson Sonsini
